Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease

Autosomal recessive polycystic kidney disease (ARPKD) is an early onset genetic disorder characterized by numerous renal cysts resulting in end stage renal disease. Our study aimed to determine if metabolic reprogramming and tryptophan (Trp) metabolism via the kynurenine pathway (KP) is a critical d...

Full description

Bibliographic Details
Main Authors: Ananda Staats Pires, Shabarni Gupta, Sean A Barton, Roshana Vander Wall, Vanessa Tan, Benjamin Heng, Jacqueline K Phillips, Gilles J Guillemin
Format: Article
Language:English
Published: SAGE Publishing 2022-10-01
Series:International Journal of Tryptophan Research
Online Access:https://doi.org/10.1177/11786469221126063
_version_ 1811161901186416640
author Ananda Staats Pires
Shabarni Gupta
Sean A Barton
Roshana Vander Wall
Vanessa Tan
Benjamin Heng
Jacqueline K Phillips
Gilles J Guillemin
author_facet Ananda Staats Pires
Shabarni Gupta
Sean A Barton
Roshana Vander Wall
Vanessa Tan
Benjamin Heng
Jacqueline K Phillips
Gilles J Guillemin
author_sort Ananda Staats Pires
collection DOAJ
description Autosomal recessive polycystic kidney disease (ARPKD) is an early onset genetic disorder characterized by numerous renal cysts resulting in end stage renal disease. Our study aimed to determine if metabolic reprogramming and tryptophan (Trp) metabolism via the kynurenine pathway (KP) is a critical dysregulated pathway in PKD. Using the Lewis polycystic kidney (LPK) rat model of PKD and Lewis controls, we profiled temporal trends for KP metabolites in plasma, urine, and kidney tissues from 6- and 12-week-old mixed sex animals using liquid and gas chromatography, minimum n  = 5 per cohort. A greater kynurenine (KYN) concentration was observed in LPK kidney and plasma of 12-week rats compared to age matched Lewis controls ( P  ⩽ .05). LPK kidneys also showed an age effect ( P  ⩽ .05) with KYN being greater in 12-week versus 6-week LPK. The metabolites xanthurenic acid (XA), 3-hydroxykynurenine (3-HK), and 3-hydroxyanthranilic acid (3-HAA) were significantly greater in the plasma of 12-week LPK rats compared to age matched Lewis controls ( P  ⩽ .05). Plasma XA and 3-HK also showed an age effect ( P  ⩽ .05) being greater in 12-week versus 6-week LPK. We further describe a decrease in Trp levels in LPK plasma and kidney (strain effect P  ⩽ .05). There were no differences in KP metabolites in urine between cohorts. Using the ratio of product and substrates in the KP, a significant age-strain effect ( P  ⩽ .05) was observed in the activity of the KYN/Trp ratio (tryptophan-2,3-dioxygenase [TDO] or indoleamine-2,3-dioxygenase [IDO] activity), kynurenine 3-monooxygenase (KMO), KAT A (kynurenine aminotransferase A), KAT B, total KAT, total KYNU (kynureninase), KYNU A, KYNU B, and total KYNU within LPK kidneys, supporting an activated KP. Confirmation of the activation of these enzymes will require verification through orthogonal techniques. In conclusion, we have demonstrated an up-regulation of the KP in alignment with progression of renal impairment in the LPK rat model, suggesting that KP activation may be a critical contributor to the pathobiology of PKD.
first_indexed 2024-04-10T06:21:28Z
format Article
id doaj.art-4382a3a482c14488ad53eabc0c7bdaf2
institution Directory Open Access Journal
issn 1178-6469
language English
last_indexed 2024-04-10T06:21:28Z
publishDate 2022-10-01
publisher SAGE Publishing
record_format Article
series International Journal of Tryptophan Research
spelling doaj.art-4382a3a482c14488ad53eabc0c7bdaf22023-03-02T04:33:09ZengSAGE PublishingInternational Journal of Tryptophan Research1178-64692022-10-011510.1177/11786469221126063Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney DiseaseAnanda Staats Pires0Shabarni Gupta1Sean A Barton2Roshana Vander Wall3Vanessa Tan4Benjamin Heng5Jacqueline K Phillips6Gilles J Guillemin7Laboratório de Bioenergética e Estresse Oxidativo, Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, BrasilAutonomic and Sensory Neuroscience Group, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, AustraliaAutonomic and Sensory Neuroscience Group, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, AustraliaAutonomic and Sensory Neuroscience Group, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, AustraliaNeuroinflammation Group, Macquarie Medical School, Centre for Motor Neuron Disease Research, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, AustraliaNeuroinflammation Group, Macquarie Medical School, Centre for Motor Neuron Disease Research, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, AustraliaAutonomic and Sensory Neuroscience Group, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, AustraliaNeuroinflammation Group, Macquarie Medical School, Centre for Motor Neuron Disease Research, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, AustraliaAutosomal recessive polycystic kidney disease (ARPKD) is an early onset genetic disorder characterized by numerous renal cysts resulting in end stage renal disease. Our study aimed to determine if metabolic reprogramming and tryptophan (Trp) metabolism via the kynurenine pathway (KP) is a critical dysregulated pathway in PKD. Using the Lewis polycystic kidney (LPK) rat model of PKD and Lewis controls, we profiled temporal trends for KP metabolites in plasma, urine, and kidney tissues from 6- and 12-week-old mixed sex animals using liquid and gas chromatography, minimum n  = 5 per cohort. A greater kynurenine (KYN) concentration was observed in LPK kidney and plasma of 12-week rats compared to age matched Lewis controls ( P  ⩽ .05). LPK kidneys also showed an age effect ( P  ⩽ .05) with KYN being greater in 12-week versus 6-week LPK. The metabolites xanthurenic acid (XA), 3-hydroxykynurenine (3-HK), and 3-hydroxyanthranilic acid (3-HAA) were significantly greater in the plasma of 12-week LPK rats compared to age matched Lewis controls ( P  ⩽ .05). Plasma XA and 3-HK also showed an age effect ( P  ⩽ .05) being greater in 12-week versus 6-week LPK. We further describe a decrease in Trp levels in LPK plasma and kidney (strain effect P  ⩽ .05). There were no differences in KP metabolites in urine between cohorts. Using the ratio of product and substrates in the KP, a significant age-strain effect ( P  ⩽ .05) was observed in the activity of the KYN/Trp ratio (tryptophan-2,3-dioxygenase [TDO] or indoleamine-2,3-dioxygenase [IDO] activity), kynurenine 3-monooxygenase (KMO), KAT A (kynurenine aminotransferase A), KAT B, total KAT, total KYNU (kynureninase), KYNU A, KYNU B, and total KYNU within LPK kidneys, supporting an activated KP. Confirmation of the activation of these enzymes will require verification through orthogonal techniques. In conclusion, we have demonstrated an up-regulation of the KP in alignment with progression of renal impairment in the LPK rat model, suggesting that KP activation may be a critical contributor to the pathobiology of PKD.https://doi.org/10.1177/11786469221126063
spellingShingle Ananda Staats Pires
Shabarni Gupta
Sean A Barton
Roshana Vander Wall
Vanessa Tan
Benjamin Heng
Jacqueline K Phillips
Gilles J Guillemin
Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease
International Journal of Tryptophan Research
title Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease
title_full Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease
title_fullStr Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease
title_full_unstemmed Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease
title_short Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease
title_sort temporal profile of kynurenine pathway metabolites in a rodent model of autosomal recessive polycystic kidney disease
url https://doi.org/10.1177/11786469221126063
work_keys_str_mv AT anandastaatspires temporalprofileofkynureninepathwaymetabolitesinarodentmodelofautosomalrecessivepolycystickidneydisease
AT shabarnigupta temporalprofileofkynureninepathwaymetabolitesinarodentmodelofautosomalrecessivepolycystickidneydisease
AT seanabarton temporalprofileofkynureninepathwaymetabolitesinarodentmodelofautosomalrecessivepolycystickidneydisease
AT roshanavanderwall temporalprofileofkynureninepathwaymetabolitesinarodentmodelofautosomalrecessivepolycystickidneydisease
AT vanessatan temporalprofileofkynureninepathwaymetabolitesinarodentmodelofautosomalrecessivepolycystickidneydisease
AT benjaminheng temporalprofileofkynureninepathwaymetabolitesinarodentmodelofautosomalrecessivepolycystickidneydisease
AT jacquelinekphillips temporalprofileofkynureninepathwaymetabolitesinarodentmodelofautosomalrecessivepolycystickidneydisease
AT gillesjguillemin temporalprofileofkynureninepathwaymetabolitesinarodentmodelofautosomalrecessivepolycystickidneydisease